Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

FHS
May 16, 2024
12:09 pm

Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.

Experts applaud Amylyx for keeping its promise to withdraw ALS drug Relyvrio after trial failure

When Amylyx brought its ALS drug before the FDA in 2022, the biotech faced questions about what it would do if a crucial Phase 3

April 5, 2024

Study highlights dangers of burning incense for allergy and asthma patients

In many cultures, it is common to burn incense for religious and cultural practices, including meditations, celebrations and spiritual and ancestral worship.

October 24, 2024

FDA widens Sarepta’s Duchenne gene therapy label to older boys in significant expansion of use

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.